Efficacy of Nilotinib Versus Imatinib in Ph+ CML in Early CP Who Have a Suboptimal Molecular Response to Imatinib

Clinical trial NCT01400074 · UNKNOWN

Trial details

NCT number: NCT01400074
Sponsor: Seoul St. Mary's Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia

Start date: 2009-01-01
Primary completion: 2014-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.